Rating Change
BTIG analysts reiterated a Buy rating on CareDx, Inc (NASDAQ:CDNA) on July 16, 2026.
reiterateNASDAQ:CDNA
BTIG Reiterates Buy Rating on CareDx, Inc (CDNA)
Rating Change BTIG analysts reiterated a Buy rating on CareDx, Inc (NASDAQ:CDNA) on July 16, 2026. Market Context CareDx, Inc operates in the Healthcare sector. The stock…
Market Context
CareDx, Inc operates in the Healthcare sector. The stock currently trades at $40.34 with a market capitalization of $1.0B.
Analyst coverage from BTIG provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for CareDx, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for CareDx, Inc
Among the 10 most recent ratings: 6 Buy, 4 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 16, 2026 | BTIG | Buy | N/A |
| Apr 29, 2026 | BTIG | Buy | N/A |
| Feb 26, 2026 | BTIG | Buy | N/A |
| Feb 25, 2026 | Wells Fargo | Equal-Weight | N/A |
| Dec 15, 2025 | Wells Fargo | Equal-Weight | N/A |
Related Tools: Analyst Ratings Dashboard | View CDNA Stock Page
Frequently Asked Questions
What does a Buy rating mean for CDNA?
A Buy rating from BTIG reflects the analyst's outlook on CareDx, Inc (NASDAQ:CDNA). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the CDNA forecast page.